Leen Kawas, PhD is a renowned figure in the biotechnology industry, with over 10 years of experience in the field. She is the CEO and President of M3 Biotechnology, a company that focuses on the development of innovative therapies for neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

Under Leen Kawas’ leadership, M3 Biotechnology has made great progress in the development of therapies for neurodegenerative diseases. The company’s lead drug candidate, NDX-1017, has promising effects in preclinical trials and is currently undergoing clinical trials for the cure of Alzheimer’s disease.

Through her passion for science and dedication to improving patient outcomes, Leen Kawas has become a prominent figure in the biotech industry. Her leadership at M3 Biotechnology has positioned the company as a leader in the development of therapies for neurodegenerative diseases.

Kawas’ expertise in the field of biotechnology has allowed her to make significant contributions to the development of innovative therapies. She is known for her visionary leadership, her ability to execute on complex projects, and her passion for science. Dr. Kawas has a deep understanding of the challenges associated with developing therapies for complex diseases and has dedicated her career to finding solutions that can improve the lives of patients.

Throughout her career, Leen has been committed to fostering diversity and inclusion in the biotech industry. She is actively involved in organizations that support women and underrepresented groups in STEM, and is passionate about creating a more equitable and inclusive industry. Dr. Kawas has been recognized for her advocacy work and has received numerous awards and accolades for her contributions to the field.

At M3 Biotechnology, Leen has assembled a team of world-class scientists and researchers who are dedicated to developing innovative therapies. The company’s lead drug candidate, NDX-1017, has shown promising results in preclinical trials and is currently undergoing clinical trials for the treatment of Alzheimer’s disease. If successful, this therapy could represent a significant breakthrough in the treatment of a disease that affects millions of people around the world.